In the pro-inflammatory setting of obesity, activated intestinal intraepithelial lymphocytes might also upregulate the expression of molecules (such as dipeptidyl peptidase 4 (DPP4)) that degrade GLP1 as another means to reduce GLP1 bioactivity during obesity38. Here, DPP4 is linked to obesity disorder.